Millennium Management
ADVM

Millennium Management’s Adverum Biotechnologies ADVM Stock Holding History

Millennium Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-21,000
Closed -$3.41M – 3419
2015
Q2 		$3.41M Buy
21,000
+20,000
+2,000% +$6.75M 0.01% 1613
2015
Q1 		$405K Buy
+1,000
New +$423K ﹤0.01% 2868

Millennium Management's ADVM Position: Q4 2025 in Review

Millennium Management sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 324,422 shares — an estimated $1.47M sold.

Millennium Management first reported a position in ADVM in Q4 2014 and held it in 38 quarters. The position peaked at $16M in Q2 2015. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.

  • Millennium Management reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
  • Millennium Management sold 324,422 Adverum Biotechnologies shares in Q4 2025, an estimated $1.47M.
  • Millennium Management first reported a position in Adverum Biotechnologies in Q4 2014 and held it in 38 quarters.
  • Millennium Management's Adverum Biotechnologies position peaked at $16M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.

Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.